ACS announces definitive agreement to acquire CredenceHealth

Affiliated Computer Services, Inc. (ACS), A Xerox Company (NYSE: XRX), today announced a definitive agreement to acquire CredenceHealth, Inc., creating a simple way for healthcare providers to use patient information to predict and prevent complications.

“Through our advanced technology that analyzes the insights found inside the massive amounts of information regarding a patient's condition, we're giving healthcare providers real-time relevant knowledge so they can better focus on giving patients the care they need”

Nashville, Tenn.-based CredenceHealth provides software that captures and analyzes patient data to assist hospitals, health plans, and providers improve quality of care and compliance with meaningful use regulations.

By integrating CredenceHealth's clinical surveillance tools with ACS' core suite of managed care solutions under the Midas software brand, ACS will now offer a cloud-based solution that actively monitors patient data - original diagnosis, laboratory and radiology reports, medications, vital signs, etc. This data is accessible to hospital staff from any Internet browser using a secure password-protected system.

The new solution, named Midas+ Live, works with a hospital's Electronic Medical Record (EMR) system, and alerts caregivers when any of thousands of possible changes in a patient's condition happen simultaneously - such as an increase in temperature or low blood pressure, combined with various lab and radiology results. This information can then be used to inform the caregiver prior to a decline in the patient's condition.

"Through our advanced technology that analyzes the insights found inside the massive amounts of information regarding a patient's condition, we're giving healthcare providers real-time relevant knowledge so they can better focus on giving patients the care they need," said Tom Simas, managing director for ACS' Midas+ solutions.

The CredenceHealth software-as-a-service offering is certified by the Office of the National Coordinator as a clinical quality measures reporting module for meaningful use. Therefore, providers using Midas+ Live will be eligible for stimulus dollars from the HITECH and American Recovery and Reinvestment Act.

"We have experienced great gains in quality outcomes and efficiencies since adding CredenceHealth's tools to our organization. Our colleagues benefit from having this information and intelligence at their fingertips," said Scott Raynes, president and CEO, NorthCrest Medical Center in Springfield, Tenn. "The addition of CredenceHealth to our existing ACS Midas+ processes and products creates a powerful combination, helping us accomplish all of the new regulatory requirements, freeing us to deliver even better care to our patients."

All CredenceHealth products and services will be integrated into Midas+ solutions, which help to improve staff efficiency, enhance patient safety and increase hospital profitability. CredenceHealth's management team and employees will join ACS. Justin Lanning, CEO, CredenceHealth, will serve as vice president of business development, ACS Midas+.